At My London Skin Clinic, advanced cancer screening is approached with care, clear information and physician-led decision-making. Trucheck™ Intelli is the only advanced multi-cancer screening blood test offered within this service. It may be considered as an additional part of a personalised preventative health review for people who want to discuss their cancer-screening options in a private Dubai clinic setting.
The purpose of the consultation is not to create unnecessary worry or to replace the screening you already need. It is to review your personal and family history, current health, age, lifestyle and any existing screening plan, then discuss whether Trucheck™ Intelli may be appropriate as an advanced screening add-on. Every recommendation is made after clinical assessment and with a clear explanation of what the test can, and cannot, tell us.
Cancer screening can feel emotionally sensitive. Some patients are motivated by a family history, others want to be more proactive about long-term health, and many simply want an informed conversation about the choices available to them. Our doctors provide a calm, unhurried consultation so that you can decide on the next step with realistic expectations and appropriate medical support.
Trucheck™ Intelli is a multi-cancer early detection, MCED, blood test from Datar Cancer Genetics. It is designed as a screening test for asymptomatic individuals and uses a blood sample to look for circulating tumour cells, CTCs, in the bloodstream. If CTCs are detected, the test is designed to provide information that may help guide assessment of the likely tissue or organ of origin.[1] [2]
The manufacturer states that Trucheck™ Intelli covers up to 70 solid tumour types. The potential coverage includes common solid tumours such as breast, lung, colorectal, prostate, pancreatic, ovarian, liver, kidney and thyroid cancers, alongside other solid tumour types.[1] This breadth is why some people choose to discuss it as an add-on to a wider preventative health review.
Trucheck™ Intelli is not a diagnostic test. It does not diagnose cancer, confirm a cancer stage or replace the investigations used to diagnose a suspected cancer. It is also not designed to detect haematological cancers, including leukaemia or lymphoma. A physician explains these boundaries before testing so that results are understood appropriately.
Your journey begins with a physician-led consultation. We discuss your current health, symptoms, personal history, family history, existing screening, medication and any concerns that may require a different diagnostic route. This is important because an advanced screening blood test is not the right first step for everyone.
Where Trucheck™ Intelli is clinically appropriate, a blood sample is taken and sent for analysis. When the report is available, your doctor reviews it with you in the context of your complete clinical picture. The result is not treated as an isolated answer. It is one piece of information that may help shape the next appropriate conversation, screening plan or investigation.
The manufacturer currently positions Trucheck™ Intelli primarily for asymptomatic people aged 40 and over, subject to clinician assessment.[2] If someone has concerning symptoms, a known cancer diagnosis or a specific clinical concern, a doctor may recommend targeted diagnostic assessment or specialist referral instead of, or in addition to, a screening discussion.
A positive or concerning Trucheck™ Intelli result does not mean that a cancer diagnosis has been made. It means further assessment is needed. Depending on the report, your symptoms, medical history and the indicated area of concern, the next step may include targeted imaging, laboratory investigations, specialist consultation or referral to an appropriate diagnostic pathway.
This follow-up is essential. Screening can identify a finding that requires more investigation, but diagnostic confirmation relies on the appropriate clinical work-up. Our role is to explain the result clearly, coordinate sensible next steps and make sure you are not left trying to interpret a complex report alone.
The pace and type of investigation are determined by your doctor and the clinical context. The aim is to be thorough without making assumptions, and to support you with clear communication throughout the process.
A negative result means that the test did not detect circulating tumour cells in the blood sample at that point in time. It can be reassuring, but it cannot completely exclude cancer. Some cancers may not release detectable cells into the bloodstream, and a screening blood test cannot rule out every disease process or replace assessment of new symptoms.
This is why a negative result should never be used to delay medical advice for concerning changes, persistent symptoms or a new lump, bleeding, pain or unexplained weight change. If you have symptoms that concern you, please seek medical assessment even if a prior screening result was negative.
A negative screening result is best viewed as part of a wider prevention plan. Your doctor can help you understand how it fits with your age, risk profile, conventional screening schedule and general health goals.
Trucheck™ Intelli may be discussed as an advanced cancer-screening add-on. It does not replace guideline-based screening recommended for specific cancers. Depending on your age, sex, family history and clinical risk, this may include mammography for breast screening, cervical screening, colorectal screening such as FIT or FOBT and colonoscopy where indicated, prostate assessment when appropriate, or other clinician-recommended checks.
Established screening programmes have their own evidence base, eligibility criteria and follow-up pathways. A multi-cancer blood test cannot take the place of these established approaches. The safest strategy is to make sure that conventional screening is up to date, then discuss whether an additional test such as Trucheck™ Intelli is relevant for you.
For patients in Dubai, this combined approach can provide a structured way to discuss preventative care. It keeps advanced technology in its proper place, as a potential supplement to, rather than a substitute for, high-quality primary care and screening.
Some asymptomatic adults over 40 may wish to discuss Trucheck™ Intelli as part of a proactive health review. People may be motivated by a family history of cancer, a desire to review their preventative health plan, frequent travel, demanding work patterns or a wish to consider an additional screening option alongside routine checks.
A consultation is particularly important if you have a strong family history, a known genetic risk, previous cancer, unexplained symptoms, an existing abnormal test result or significant anxiety about cancer. In these situations, the doctor can explain whether screening, genetic counselling, specialist review or targeted diagnostic investigation is the most appropriate next step.
The decision is individual. The clinic will not present Trucheck™ Intelli as essential for every patient or as a replacement for an appropriate doctor-patient conversation.
Advanced screening results can be difficult to interpret without clinical context. A report may raise questions about further tests, the likelihood of an underlying finding and the most appropriate specialist pathway. Careful physician-led interpretation helps ensure that results lead to proportionate, evidence-aware next steps rather than unnecessary alarm.
At My London Skin Clinic, the focus is on informed prevention. We explain the possible advantages and limitations of Trucheck™ Intelli before testing, review the result with you after testing and help coordinate next steps if further assessment is needed. This approach prioritises clarity, patient safety and long-term wellbeing.
Dubai residents often manage demanding professional schedules, family responsibilities, international travel and changes in healthcare systems after relocation. A private, physician-led screening consultation can help bring existing health information together and identify which preventative checks are sensible to discuss.
Our clinic provides a discreet environment for discussing Trucheck™ Intelli alongside conventional screening, personal history and lifestyle factors. The goal is not to over-test or to promise certainty. It is to help you make a balanced, informed decision about your preventative health plan in the UAE.
No. It is a screening test. A positive or concerning result requires targeted imaging, investigation and, where appropriate, specialist assessment before a diagnosis can be made.
It looks for circulating tumour cells, CTCs, in a blood sample. If detected, the report may help guide assessment of the likely tissue or organ of origin
The manufacturer states that Trucheck™ Intelli can cover up to 70 solid tumour types.[1] It is not designed to detect blood cancers such as leukaemia or lymphoma.
No. A negative result means no circulating tumour cells were detected in that sample at that time. It cannot completely exclude cancer or replace medical assessment of concerning symptoms.
No. It is an advanced screening add-on and does not replace guideline-based screening such as mammography, cervical screening, colorectal screening, colonoscopy or other tests recommended by your doctor.
The manufacturer positions Trucheck™ Intelli primarily for asymptomatic adults aged 40 and over, with clinician assessment.[2] Your doctor can discuss whether this is appropriate for you.
Your doctor will discuss the report and arrange or recommend appropriate targeted follow-up, which may include imaging, further tests or specialist referral. A positive screening result is not a diagnosis.
If you have new or concerning symptoms, please arrange a medical assessment. A doctor can determine whether a targeted diagnostic pathway is more appropriate than, or should accompany, a screening test.
To discuss whether Trucheck™ Intelli may be an appropriate advanced screening add-on for you, contact My London Skin Clinic to arrange a physician-led consultation. Your doctor can review your history, explain the possible role and limitations of the test and help you make an informed decision about next steps.
Your booking summary:
